Bristol Myers Raises 2026 Revenue Forecast, Lowers EPS Outlook
Bristol Myers Squibb raised its full-year 2026 revenue forecast, citing strong sales of newer medicines, while lowering its 2026 earnings-per-share projection due to an acquisition-related charge.
Story updates
10:59:18 AM UTC
SquawkNews
Bristol Myers Squibb Raises 2026 View To Rev $49.75B-$50.25B Vs Prior View $49B-$50B >BMY
By Deena BeasleyBristol Myers Squibb NYSE:BMY raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share projection due to a hefty acquisition-related charge.The US drugmaker said it now expects 2026 adjusted earnings of…